Oncolytic Virotherapy Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 March 04
SKU : PH5020
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What is the Projected CAGR value of the Oncolytic Virotherapy Market?
Oncolytic Virotherapy Market is expected to grow at a CAGR of 23.07% during the forecasting period 2024-2031.
Which region controlled the global market during 2023-2030?
North America region Controls the Oncolytic Virotherapy Market during 2024-2031.
Which is the fastest-growing region in the Oncolytic Virotherapy Market?
Among all regions, Asia Pacific is the fastest-growing market share during the forecast period.
Who are the key players in the Oncolytic Virotherapy Market?
Amgen Inc., Shanghai Sunway Biotech Co., Ltd., TILT Biotherapeutics Ltd., Oncorus, Inc., Takara Bio Inc., Vyriad, Transgene SA, Lokon Pharma AB, Pfizer Inc., Roche., AstraZeneca.
Related Reports
pharmaceuticals

Oncolytic Virus Therapy Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 May 14
Starting from

$4350

pharmaceuticals

Oncology Therapy Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 May 21
Starting from

$4350

medical-devices

Colon Hydrotherapy Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 14
Starting from

$4350

pharmaceuticals

Cold Pain Therapy Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 16
Starting from

$4350

pharmaceuticals

Cancer Immunotherapy Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 May 13
Starting from

$4350

medical-devices

Photodynamic Therapy Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 05
Starting from

$4350